Both in Biotechnology
CG Oncology vs Kodiak Sciences
Over the past year CGON returned +49.5% and KOD returned +447.2%; their daily moves had a correlation of 0.22.
CGON +49.5% KOD +447.2%Growth of $1, one year, split-adjusted
| Metric | CGON | KOD |
|---|---|---|
| Price | $64.68 | $99.18 |
| Market cap | $5.73B | $6.23B |
| Today | +1.91% | −1.22% |
| 1 month | −5.4% | +0.7% |
| 6 months | −2.4% | +125.6% |
| Year to date | +55.8% | +254.7% |
| 1 year | +50.5% | +423.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | −239.2% | — |
| Net margin | −6832.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 920.6× | — |
| Net cash | $1.03B | $125.9M |
| Dividend yield | — | — |
| Volatility (60d) | 40.3% | 217.1% |
| Short % of float | 12.9% | 28.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).